Compound ID | 3316
Synonym(s): ABAC40411 | ABAC 40411
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Streptococcus pneumoniae; intended indication for community acquired pneumonia (CAP) and other upper respiratory infections (URTI) |
| Institute where first reported: | ABAC Therapeutics |
| Year first mentioned: | 2024 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citations: |
|